The quest for innovative strategies in promoting healthy aging has led researchers to explore the enhancement of enzymatic functions, particularly focusing on sirtuins. Published in Physical Review X, a recent paper sheds light on an intriguing approach to energizing these enzymes to maintain their efficiency, particularly through their dependence on nicotinamide adenine dinucleotide (NAD+).

Rethinking Enzyme Activation

Traditionally, pharmacological interventions aim to inhibit specific enzymes as a means to treat various diseases. However, this research diverges from that paradigm by aiming to enhance rather than inhibit enzyme activity. Sirtuins, a family of enzymes recognized for their role in regulating cellular processes related to aging, utilize NAD+ for their function [1]. Evidence suggests that upregulating sirtuins can extend lifespan in mammalian models [2].

NAD+ and its Limitations

Most methods aimed at boosting sirtuin activity have employed allosteric activation, which relies on altering the activity of enzymes through the binding of regulatory molecules. However, the inherent limitations of available substrates restricts this method’s efficacy [3]. Furthermore, while NAD+ is crucial for sirtuin function, efforts to elevate NAD+ levels in a generalized manner present challenges; such a broad approach may lead to unwanted side effects [4]. Additionally, the cellular machinery required to convert NAD+ into its phosphate form, NADH, may not function optimally in aging cells [5].

New Directions in Sirtuin Activation

The researchers propose an innovative approach to enhance sirtuins’ functionality even when NAD+ levels are suboptimal. They are attempting to create a steady-state activator that consistently supports sirtuin activity without requiring peak supplies of NAD+. To achieve this, they decided to investigate SIRT3, an enzyme linked with mitochondrial health [7] and identified as beneficial in previous studies targeting mitochondrial dysfunction [8].

Compound Discovery: A Computational Journey

The research team utilized advanced algorithms to sift through a library of approximately 1.2 million compounds. Starting with Honokiol, previously known to only conditionally activate SIRT3, researchers successfully identified compounds capable of both steady-state and non-steady-state activation. They further refined their search by focusing on compounds forming strong interactions with critical amino acids within the SIRT3 protein.

Validation of Compounds

To ensure reliability, the identified compounds were tested on real SIRT3 substrates. Unlike many studies that utilize fluorescent labeling—which could distort biological reactions—the authors opted for a more straightforward approach. Among the candidates, compound number 5689785 emerged as a strong activator, demonstrating superior performance compared to both honokiol and nicotinamide mononucleotide (NMN).

Parameter 5689785 Honokiol NMN
Activation of SIRT3 High Conditional Moderate
Restoration of NAD+ Activity yes No Yes
Effect on Mitochondrial Function Beneficial Limited Neutral

Prospects for Future Research

Despite the promising results, 5689785 is not yet a consumable drug, and researchers have not conducted any animal studies to date. The current phase represents a significant step toward validating the potential of directly enhancing sirtuin activity without relying solely on substrate-based mechanisms. If successful in future animal models, such a strategy may lead to innovative drugs targeting various aspects of aging due to SIRT3’s critical role in mitochondrial health.

Continued exploration in this field holds the promise not only for longevity but also for enhancing the quality of life as we age.

Conclusion

The pursuit of effective aging interventions is crucial in contemporary medical research. By enhancing the performance of enzymes like sirtuins, particularly through innovative activation strategies, researchers are laying the groundwork for revolutionary therapeutic approaches aimed at prolonging healthy lifespan.

Literature Cited

  • [1] Kaeberlein, M., McVey, M., & Guarente, L. (1999). The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes & Development, 13(19), 2570-2580.
  • [2] Roichman, A., et al. (2021). Restoration of energy homeostasis by SIRT6 extends healthy lifespan. Nature Communications, 12(1), 3208.
  • [3] Sinclair, D. A., & Guarente, L. (2014). Small-molecule allosteric activators of sirtuins. Annual Review of Pharmacology and Toxicology, 54(1), 363-380.
  • [4] Yang, T., & Sauve, A. A. (2006). NAD metabolism and sirtuins: metabolic regulation of protein deacetylation in stress and toxicity. The AAPS Journal, 8, E632-E643.
  • [5] Hu, Q., et al. (2021). Genetically encoded biosensors for evaluating NAD+/NADH ratio in cytosolic and mitochondrial compartments. Cell Reports Methods, 1(7).
  • [6] Reverdy, C., et al. (2022). Discovery of novel compounds as potent activators of SIRT3. Bioorganic & Medicinal Chemistry, 73, 116999.
  • [7] Van de Ven, R. A., Santos, D., & Haigis, M. C. (2017). Mitochondrial sirtuins and molecular mechanisms of aging. Trends in Molecular Medicine, 23(4), 320-331.
  • [8] Cantó, C., et al. (2012). The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metabolism, 15(6), 838-847.
  • [9] Bellizzi, D., et al. (2005). A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics, 85(2), 258-263.
  • [10] Lifespan.io